CorePoint Lodging Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018
Assets:
Real estate:
Land
Buildings and improvements
Furniture, fixtures, and other equipment
Gross operating real estate
Less accumulated depreciation
Net operating real estate
Construction in progress
Total real estate, net
Right of use assets
Cash and cash equivalents
Accounts receivable, net of allowance for doubtful accounts of $4,169 and $4,296
Assets held for sale
Other current assets
Total Current Assets
Property and equipment, net of accumulated depreciation
Intangible assets, net of accumulated amortization
Other non-current assets
Total Non-Current Assets
Accounts receivable
Lender and other escrows
Other assets
Assets from discontinued operations
Total Assets

Liabilities and Equity:
Current portion of long-term debt
Accounts payable
Accrued expenses and other liabilities
Accrued payroll and employee benefits
Accrued real estate taxes
Total Current Liabilities
Long-term debt
Other long-term liabilities
Liabilities:
Debt, net
Mandatorily redeemable preferred stock
Accounts payable and accrued expenses
Dividends payable
Other liabilities
Deferred tax liabilities
Deferred tax liabilities
Total Liabilities
Equity:
Preferred stock, $0.01 par value; 50.0 million shares authorized as of March 31, 2019 and December 31, 2018; 15.0 thousand shares outstanding as of March 31, 2019 and December 31, 2018
Common stock, $0.01 par value per share; 1.0 billion shares authorized; 58.4 million and 58.0 million shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
Additional paid-in-capital
Accumulated deficit
Treasury stock, at cost, 7.6 million shares as of December 31, 2017
Accumulated other comprehensive loss
Noncontrolling interest
Total Equity

Total Liabilities and Equity

Comments